Novochizol SA researches and develops applications of Novochizol, a unique chitosan nanoparticle technology that yields different carriers of small molecules, peptides, nucleic acids and proteins for sustained, localized delivery to any living tissue, with intracellular targeting potential.

Products, services, technology

Novochizol is being developed as a drug delivery system in the areas of immuno-oncology (intratumoral administration of engineered cytokines), rerspiratory diseases (aerosol formulations of APIs) and as fillers ( dermofillers and intra-joint fillers).

Cooperation possibilities

Novochizol technology may be out-licensed, we can engage in R&D joint ventures and we can manufacture formulations in pharma, agriculture and diagnostic domains.

You may also be interested in